Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garnero

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|January 12, 2005
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatmentK Briot, P Garnero, A Le Henanff, et al.
Cytokine|January 9, 2001
Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditionsM Chabaud, T Aarvak, P Garnero, et al.
Bone|April 30, 1999
Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown productsP Garnero, P Jouvenne, N Buchs, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 1996
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosisP Garnero, E Sornay-Rendu, M C Chapuy, et al.
Bone|January 25, 2005
Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS studyP Szulc, P Garnero, F Marchand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2007
Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastasesJ-J Body, M Lichinitser, S Tjulandin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2001
Cross-sectional evaluation of bone metabolism in menP Szulc, P Garnero, F Munoz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1995
Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretionP Garnero, E Gineyts, P Arbault, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1993
Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's diseaseP D Delmas, E Gineyts, A Bertholin, et al.
Bone|February 22, 2008
Establishing a reference range for bone turnover markers in young, healthy womenS J Glover, P Garnero, K Naylor, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|January 12, 2005
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatmentK Briot, P Garnero, A Le Henanff, et al.
Cytokine|January 9, 2001
Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditionsM Chabaud, T Aarvak, P Garnero, et al.
Bone|April 30, 1999
Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown productsP Garnero, P Jouvenne, N Buchs, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 1, 1996
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosisP Garnero, E Sornay-Rendu, M C Chapuy, et al.
Bone|January 25, 2005
Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS studyP Szulc, P Garnero, F Marchand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2007
Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastasesJ-J Body, M Lichinitser, S Tjulandin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 8, 2001
Cross-sectional evaluation of bone metabolism in menP Szulc, P Garnero, F Munoz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1995
Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretionP Garnero, E Gineyts, P Arbault, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1993
Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's diseaseP D Delmas, E Gineyts, A Bertholin, et al.
Bone|February 22, 2008
Establishing a reference range for bone turnover markers in young, healthy womenS J Glover, P Garnero, K Naylor, et al.
Pageof 15